Cefonus-T 500mg/62.5mg Injection
Marketer
Cronus Biotech Ltd
Salt Composition
Ceftriaxone (500mg) + Tazobactum (62.5mg)
Overview Cefonus-T 500mg/62.5mg Injection
Ticef-CT 500mg/62.5mg injection, a dual-action antibiotic, combats various bacterial infections by inhibiting microbial proliferation. Administration must be solely under a physician's guidance; strictly adhere to the prescribed dosage schedule. Complete the full treatment course, regardless of symptom improvement, as premature cessation may compromise efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia; worsening symptoms necessitate immediate medical attention. Seek immediate medical help for allergic reactions (e.g., rash, pruritus, edema, dyspnea). Inform your doctor about all current medications, including those for pre-existing conditions. Pregnant or lactating individuals require prior medical consultation. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing to driving ability, avoid driving if drowsiness or dizziness occurs. Adequate rest, balanced nutrition, and hydration contribute to faster recovery. Monitoring via laboratory tests may be implemented to assess treatment effectiveness.
Uses of Cefonus-T 500mg/62.5mg Injection
Infections caused by bacteria
Major Benefits of Cefonus-T 500mg/62.5mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Cefonus-T 500mg/62.5mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Cefonus-T 500mg/62.5mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Cefonus-T 500mg/62.5mg Injection works:
Ceftriaxone and Tazobactum, combined as Cefonus-T 500mg/62.5mg Injection, offer a targeted antibacterial approach. Ceftriaxone, a third-generation cephalosporin antibiotic, disrupts bacterial cell wall synthesis, inhibiting bacterial growth and survival. Tazobactum's role as a beta-lactamase inhibitor counters bacterial resistance mechanisms, thus maximizing Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Ingestion of alcohol alongside Cefonus-T 500mg/62.5mg Injection poses no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Cefonus-T 500mg/62.5mg is typically deemed safe for use in pregnant individuals. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; nonetheless, clinical data from human studies are scarce.
Breast feedingCAUTION
The administration of Cefonus-T 500mg/62.5mg Injection to breastfeeding mothers requires careful consideration. It's recommended to discontinue breastfeeding for the duration of maternal treatment and until the medication is fully cleared from the mother's system.
DrivingUNSAFE
The administration of Cefonus-T 500mg/62.5mg Injection can induce drowsiness, blurred vision, and dizziness. Refrain from operating a vehicle should these effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Cefonus-T 500mg/62.5mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
The injectable formulation of Cefonus-T (500mg/62.5mg) requires careful administration in individuals with advanced hepatic impairment. Dosage modification of Cefonus-T (500mg/62.5mg) injection may be necessary. Physician consultation is advised. Altering the dose of Cefonus-T (500mg/62.5mg) injection is not suggested for patients experiencing mild to moderate liver dysfunction.
What if you forget to take Cefonus-T 500mg/62.5mg Injection :
Omit a Cefonus-T 500mg/62.5mg Injection dose? Seek your physician's advice.
Facts to Know About Cefonus-T 500mg/62.5mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Antimicrobial Agents |
3,018 People bought this recently